⌕
GoodRx Holdings · GDRX · Nasdaq
Tenet 51 · Mixed
Compare
$3.47−1.14%At closeTenet 51 · Mixed
$3.47−0.04 (−1.14%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

GoodRx Holdings (GDRX) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~1.7%/yr (FY21→FY25), net margin 3.8%, and free cash flow (~$93.9M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($M)▲0.6%
796.9
FY21→FY25CAGR +1.7%/yr
Net income ($M)▲85.7%
30.4
one-off year: see footnoteCAGR —
Free cash flow ($M)▼17.3%
93.9
FY21→FY25CAGR −10.2%/yr
Diluted EPS▲125.0%
0.09
buyback-liftedCAGR —
What the receipts whisper · what a headline number hides
Share count
−12.9%

410.0mn → 357.0mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$74.0M

steady at 9.3% of revenue (+5.2% YoY).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)796.9Revenue−57.6COGS739.3Gross profit−121.0R&D−114.0SG&A87.5Op income−57.1Tax & other30.4Net income

4¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
1007550250%sector median net margin ~3%FY21FY25

Over this window: gross 93.7% → 92.8%. Net margin 3.8% is above the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
785.2796.9792.3750.3766.6745.4▲0.6%+1.7%
Cost of revenue
72.057.648.266.965.146.7▲19.5%+5.4%
Gross profit
713.2739.3744.1683.3701.5698.7▼0.7%+1.4%
Research & development
116.8121.0123.7135.8143.1125.9▼2.2%−1.0%
Selling, general & admin
107.6114.0117.9125.5144.8154.7▼3.3%−7.4%
Total operating expenses
638.2651.8678.3710.3699.7685.3▼3.9%−1.2%
Operating incomefeeds ROC rank
74.987.565.8−27.01.713.4▲32.9%+59.8%
Other income, net
−33.5−31.0−34.4−28.6−25.0−23.6——
Pretax income
41.456.531.5−55.6−23.2−10.2▲79.7%—
Income tax
25.126.115.1−46.79.615.1▲73.2%+14.7%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
16.230.416.4−8.9−32.8−25.3▲85.7%—
Per share
Diluted EPSbuyback-sensitive
0.040.090.04−0.02−0.08−0.06▲125.0%—
Diluted shares (mn)
348.06356.97392.17410.31412.86409.98▼9.0%−3.4%
Margins
Gross margin87th pct in Healthcare
90.8%92.8%93.9%91.1%91.5%93.7%▼1.1pp−1.0pp
Operating margin
9.5%11.0%8.3%−3.6%0.2%1.8%▲2.7pp+9.2pp
Net margin45th pct in Healthcare
2.1%3.8%2.1%−1.2%−4.3%−3.4%▲1.8pp+7.2pp
† TTM = trailing four quarters through 2026-06-30.FY21 effective tax rate was −148% vs a 46% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was −41% vs a 46% norm for this window, likely a one-time item; see the filing.
FY18 – FY20 · 3 more years
Unlock the full history →
3 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was GoodRx Holdings' revenue last fiscal year?

GoodRx Holdings reported revenue of $796.9M in fiscal 2025, up 0.6% from fiscal 2024.

What was GoodRx Holdings' net income?

GoodRx Holdings reported net income of $30.4M in fiscal 2025, a net margin of 3.8%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.